title: Efficacy and tolerability of clindamycin phosphate and salicylic acid gel in the treatment of mild to moderate acne vulgaris.
authors.forename: E
authors.initials: E
authors.lastname: Touitou
authors.forename: B
authors.initials: B
authors.lastname: Godin
authors.forename: M
authors.initials: M
authors.lastname: Shumilov
authors.forename: N
authors.initials: N
authors.lastname: Bishouty
authors.forename: D
authors.initials: D
authors.lastname: Ainbinder
authors.forename: R
authors.initials: R
authors.lastname: Shouval
authors.forename: A
authors.initials: A
authors.lastname: Ingber
authors.forename: V
authors.initials: V
authors.lastname: Leibovici
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy* / Q000473:pathology; D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002981:Clindamycin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007641:Keratolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D020156:Salicylic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D012720:Severity of Illness Index
chemical_list: D000900:Anti-Bacterial Agents; D007641:Keratolytic Agents; D002981:Clindamycin; C007084:clindamycin phosphate; D020156:Salicylic Acid